|
TMEM106C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.521000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.943800E-01 |
| Normal-vs-Stage2 |
2.019600E-01 |
| Normal-vs-Stage3 |
2.546800E-01 |
| Normal-vs-Stage4 |
4.186200E-01 |
| Stage1-vs-Stage2 |
1.584190E-01 |
| Stage1-vs-Stage3 |
2.425000E-01 |
| Stage1-vs-Stage4 |
4.488200E-01 |
| Stage2-vs-Stage3 |
3.355700E-02 |
| Stage2-vs-Stage4 |
7.586400E-02 |
| Stage3-vs-Stage4 |
9.065600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.023600E-01 |
| Normal-vs-AfricanAmerican |
6.825800E-01 |
| Normal-vs-Asian |
2.808800E-01 |
| Caucasian-vs-AfricanAmerican |
4.910400E-01 |
| Caucasian-vs-Asian |
1.135970E-01 |
| AfricanAmerican-vs-Asian |
6.742600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.607500E-02 |
| Normal-vs-Female |
7.125200E-01 |
| Male-vs-Female |
1.021500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.591400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.670000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.594200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.344300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.977000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.200400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.697360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.352600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.279600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.887440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.228100E-02 |
| Classical-VS-Follicular |
3.668800E-01 |
| Classical-VS-Other |
8.604400E-01 |
| Classical-VS-Normal |
9.368000E-01 |
| Tall-VS-Follicular |
1.561860E-02 |
| Tall-VS-Other |
4.129000E-01 |
| Tall-VS-Normal |
3.873800E-02 |
| Follicular-VS-Other |
6.665000E-01 |
| Follicular-VS-Normal |
4.706800E-01 |
| Other-VS-Normal |
8.021200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.210800E-01 |
| Normal-vs-N1 |
8.989700E-02 |
| N0-vs-N1 |
2.673900E-02 |
|
|
